1. Home
  2. VVOS vs XAIR Comparison

VVOS vs XAIR Comparison

Compare VVOS & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$0.09

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

SELL

Current Price

$2.59

Market Cap

3.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
VVOS
XAIR
Founded
2016
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6M
3.0M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
VVOS
XAIR
Price
$0.09
$2.59
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$1.93
★ $20.00
AVG Volume (30 Days)
★ 1.6M
20.4K
Earning Date
11-23-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 6.76
N/A
EPS
★ N/A
N/A
Revenue
★ $17,443,000.00
$7,679,000.00
Revenue This Year
$24.92
$4.23
Revenue Next Year
$56.44
$108.84
P/E Ratio
N/A
★ N/A
Revenue Growth
16.05
★ 107.26
52 Week Low
$0.09
$0.33
52 Week High
$2.69
$8.19

Technical Indicators

Market Signals
Indicator
VVOS
XAIR
Relative Strength Index (RSI) 22.35 52.19
Support Level N/A $2.38
Resistance Level $0.36 $3.30
Average True Range (ATR) 0.01 0.19
MACD -0.00 0.07
Stochastic Oscillator 4.91 73.33

Price Performance

Historical Comparison
VVOS
XAIR

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About XAIR Beyond Air Inc.

Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.

Share on Social Networks: